FFR与IVUS指导PCI的长期结局:FLAVOUR试验延长随访
FLAVOUR延长随访纳入1682例中度冠状动脉狭窄患者,随机接受FFR或IVUS指导治疗,中位随访6.3年。两组主要复合终点无显著差异(23.1% vs 20.9%,HR 1.15,95%CI 0.93-1.42,P=0.208),但FFR组靶血管再次血运重建率更高(9.6% vs 6.2%,HR 1.67,95%CI 1.15-2.43,P=0.007),而包含指数PCI的总体靶血管PCI率FFR组显著更低(38.8% vs 60.5%,P<0.001)。
要点
- FFR与IVUS指导的中度狭窄患者长期硬终点无显著差异。
- FFR组靶血管晚期再次血运重建率更高,尤其初始推迟PCI的血管。
- FFR组包含指数手术的总体靶血管PCI率显著低于IVUS组。
核心结论
- FFR指导与IVUS指导治疗策略的长期患者导向复合结局无显著差异。
- FFR指导组靶血管晚期血运重建率更高,但总体靶血管PCI率仍显著低于IVUS组。
研究设计与样本
- 多国、随机、开放标签试验,纳入年龄≥19岁、新发中度冠状动脉狭窄(40%-70%)、靶血管直径≥2.5 mm的患者。
- 共1682例患者随机1:1接受FFR指导(n=838)或IVUS指导(n=844)治疗,来自韩国和中国18个中心。
- 延长随访至2024年9月,中位随访6.3年(Q1-Q3:5.6-6.9年)。
主要发现
- 主要终点(全因死亡、心肌梗死和指数术后任何血运重建复合)FFR组179例(23.1%),IVUS组160例(20.9%),HR 1.15(95%CI 0.93-1.42),P=0.208。
- 指数术后血运重建率FFR组113例(14.9%),IVUS组87例(11.8%),HR 1.32(95%CI 1.00-1.75),P=0.049。
- 靶血管血运重建率FFR组72例(9.6%),IVUS组44例(6.2%),HR 1.67(95%CI 1.15-2.43),P=0.007。
- 2年Landmark分析和按血管分析提示,FFR组较高的再次血运重建率主要源于初始推迟PCI血管的晚期(2-7年)血运重建。
- 包含指数PCI和随访期间血运重建的总体靶血管PCI率FFR组38.8%,IVUS组60.5%,P<0.001;两组死亡或心肌梗死年累积发生率无显著差异。
临床怎么用
- FFR指导可在不增加长期硬终点风险的前提下减少总体靶血管PCI率。
- 对FFR指导推迟PCI的血管,需关注2-7年晚期靶血管血运重建风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The optimal treatment strategy for patients with intermediate coronary stenosis remains uncertain. OBJECTIVES: The aim of this study was to investigate the long-term outcomes of a randomized, open-label, multinational trial comparing fractional flow reserve (FFR)-guided vs intravascular ultrasound (IVUS)-guided treatment strategies. METHODS: Patients aged ≥19 years with de novo intermediate coronary stenosis (40%-70%) and target vessel diameters ≥2.5 mm were randomized 1:1 to FFR- or IVUS-guided treatment across 18 sites in Korea and China. The primary endpoint was a composite of all-cause death, myocardial infarction, and any revascularization occurring after the index procedure. Secondary endpoints included individual components of the primary outcome and per vessel outcomes according to treatment type. Extended follow-up continued through September 2024. RESULTS: Between July 2016 and August 2019, 1,682 patients were assigned to the FFR-guided (n = 838) and IVUS-guided (n = 844) groups. Over a median follow-up period of 6.3 years (Q1-Q3: 5.6-6.9 years), the primary outcome occurred in 339 patients (22.0%), with no statistically significant difference between groups (179 [23.1%] for FFR vs 160 [20.9%] for IVUS; HR: 1.15; 95% CI: 0.93-1.42; P = 0.208). The revascularization rate after the index procedure was higher in the FFR group (113 [14.9%] vs 87 [11.8%]; HR: 1.32; 95% CI: 1.00-1.75; P = 0.049), particularly for target vessel revascularization (72 [9.6%] vs 44 [6.2%]; HR: 1.67; 95% CI: 1.15-2.43; P = 0.007). Landmark analysis at 2 years and per vessel analyses indicated that the higher revascularization rate after the index procedure was driven primarily by late (2-7 years) revascularizations in vessels in which percutaneous coronary intervention (PCI) was initially deferred. Nevertheless, the overall rate of target vessel PCI, including procedures at index and during follow-up, was significantly lower in the FFR group (38.8% vs 60.5%; P < 0.001), with no statistically significant differences in the annual cumulative incidence of death or myocardial infarction between groups. CONCLUSIONS: FFR-guided and IVUS-guided treatment strategies resulted in comparable long-term outcomes, with no significant difference in patient-oriented composite outcomes. Although FFR-guided treatment was associated with a higher incidence of late target vessel revascularization, the overall target vessel PCI rate, accounting for both the index procedure and revascularization during follow-up, remained significantly lower in the FFR-guided treatment group, with comparable rates of hard outcomes between the 2 groups.
引用
- Yang S, Hu X, Zhang J, et al. Long-Term Outcomes After Fractional Flow Reserve vs Intravascular Ultrasound to Guide PCI: The FLAVOUR Trial Extended Follow-Up. J Am Coll Cardiol. 2025. PMID: 40835367. doi:10.1016/j.jacc.2025.06.042
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。